Aarkstore Adalimumab – Key patent, SPC, and data exclusivity expiry (44 country coverage)

Aarkstore announce a new report " Adalimumab - Key patent, SPC, and data exclusivity expiry (44 country coverage)" through its vast collection of market research report

ListFree.org (Press Release) - Tuesday, July 10th, 2012 -

http://www.aarkstore.com/categories/index.asp

Adalimumab – Key patent, SPC, and data exclusivity expiry (44 country coverage)

Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players.

This Pipeline Selector report covers Adalimumab
Adalimumab indications: Rheumatoid arthritis; polyarticular juvenile idiopathic arthritis; psoriatic arthritis; ankylosing spondylitis; Crohn’s disease and plaque psoriasis
Adalimumab innovator: Abbott (Humira)

Examples of information found in this online report include:
# Includes key patent publications for 44 countries (see list below)
# Contains SPC protection for every EU state plus patent term extensions in other countries
# Data exclusivity calculated on a country by country basis
# Summary of dosage forms, strengths, indications and active ingredient forms of the brand product
# DMF & Paragraph IV filings
# Litigation alerts
# Marketing authorisation holders in selected territories
# Patent risk analysis via graphical display of data from patent filings
# Hyper-linking to crucial patent documents and national registries enabling data verification

The ‘Key Patent Indicator’ enables easy identification of key patent, SPC and data protection expiry information covering 44 countries, including extension details (SPC and national law) for 30 European countries, Australia, Israel, Japan and the USA. (also available with 44 country coverage):

For more information, please visit :-

http://www.aarkstore.com/reports/Adalimumab-Key-patent-SPC-and-data-exclusivity-expiry-44-country-coverage–91047.html

Marketing Team

Aarkstore Enterprise

Phone:08149852585

Email:enquiry@aarkstore.com

URL:www.aarkstore.com

http://twitter.com/aarkstoredotcom

http://in.linkedin.com/in/aarkstore

http://www.facebook.com/aarkstoreenterprise

More Related Reports :-

Varenicline – Key patent, SPC, and data exclusivity expiry (44 country coverage)
Abacavir – Key patent, SPC, and data exclusivity expiry (44 country coverage)
Acitretin – Key patent, SPC, and data exclusivity expiry (44 country coverage)
Adalimumab – Key patent, SPC, and data exclusivity expiry (44 country coverage)
Adefovir – Key patent, SPC, and data exclusivity expiry (44 country coverage)
Alendronic Acid – Key patent, SPC, and data exclusivity expiry (44 country coverage)
Alendronic Acid (Ext) – Key patent, SPC, and data exclusivity expiry (44 country coverage)
Alverine – Key patent, SPC, and data exclusivity expiry (44 country coverage)
Amphotericin B – Key patent, SPC, and data exclusivity expiry (44 country coverage)
Aripiprazole – Key patent, SPC, and data exclusivity expiry (44 country coverage)

ListFree.org: Embedded data.

Bookmark and Share Subscribe

pdf

 

Contact us at :
Issued By:Poojaarark
Email:Pooja.S.1973@gmail.com
Town:Navi Mumbai
Country:India
Phone:8149852585
WebSite:http://www.aarkstore.com/
Categories:Uncategorized
Tags:

You can leave a response, or trackback from your own site.


Related Posts
    No matches

Leave a Reply

You must be logged in to post a comment.